Gsa Capital Partners LLP Maravai Lifesciences Holdings, Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$4.7 - $9.87 $229,557 - $482,070	48,842 New	48,842 $319,000
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $687,200 - $1.36 Million	54,976 New	54,976 $787,000
Q2 2022 Aug 09, 2022	SELL	$26.05 - $37.48 $263,469 - $379,072	-10,114 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$24.46 - $40.92 $247,388 - $413,864	10,114 New	10,114 $357,000
Q3 2021 Nov 12, 2021	SELL	$36.8 - $60.62 $297,896 - $490,718	-8,095 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$32.46 - $45.0 $262,763 - $364,275	8,095 New	8,095 $338,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.